ID   PDE2A_RAT               Reviewed;         928 AA.
AC   Q01062;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   02-OCT-2024, entry version 168.
DE   RecName: Full=cGMP-dependent 3',5'-cyclic phosphodiesterase {ECO:0000250|UniProtKB:O00408};
DE            EC=3.1.4.17 {ECO:0000250|UniProtKB:O00408};
DE   AltName: Full=Cyclic GMP-stimulated phosphodiesterase {ECO:0000303|PubMed:7811274};
DE            Short=CGS-PDE {ECO:0000303|PubMed:7811274};
DE            Short=cGSPDE {ECO:0000303|PubMed:7811274};
GN   Name=Pde2a {ECO:0000312|RGD:620965};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7811274; DOI=10.1006/bbrc.1994.2886;
RA   Yang Q., Paskind M., Bolger G., Thompson W.J., Repaske D.R., Cutler L.S.,
RA   Epstein P.M.;
RT   "A novel cyclic GMP stimulated phosphodiesterase from rat brain.";
RL   Biochem. Biophys. Res. Commun. 205:1850-1858(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 643-759.
RX   PubMed=1326532; DOI=10.1016/s0021-9258(19)37015-2;
RA   Repaske D.R., Swinnen J.V., Jin S.-L.C., van Wyk J.J., Conti M.;
RT   "A polymerase chain reaction strategy to identify and clone cyclic
RT   nucleotide phosphodiesterase cDNAs. Molecular cloning of the cDNA encoding
RT   the 63-kDa calmodulin-dependent phosphodiesterase.";
RL   J. Biol. Chem. 267:18683-18688(1992).
RN   [3]
RP   SUBCELLULAR LOCATION (ISOFORM PDE2A2), AND TISSUE SPECIFICITY.
RX   PubMed=21724846; DOI=10.1074/jbc.m111.266379;
RA   Acin-Perez R., Russwurm M., Gunnewig K., Gertz M., Zoidl G., Ramos L.,
RA   Buck J., Levin L.R., Rassow J., Manfredi G., Steegborn C.;
RT   "A phosphodiesterase 2A isoform localized to mitochondria regulates
RT   respiration.";
RL   J. Biol. Chem. 286:30423-30432(2011).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   FUNCTION (ISOFORM PDE2A2), SUBCELLULAR LOCATION (ISOFORM PDE2A2), AND
RP   ACTIVITY REGULATION.
RX   PubMed=28463107; DOI=10.7554/elife.21374;
RA   Monterisi S., Lobo M.J., Livie C., Castle J.C., Weinberger M., Baillie G.,
RA   Surdo N.C., Musheshe N., Stangherlin A., Gottlieb E., Maizels R.,
RA   Bortolozzi M., Micaroni M., Zaccolo M.;
RT   "PDE2A2 regulates mitochondria morphology and apoptotic cell death via
RT   local modulation of cAMP/PKA signalling.";
RL   Elife 6:0-0(2017).
CC   -!- FUNCTION: cGMP-activated cyclic nucleotide phosphodiesterase with a
CC       dual-specificity for the second messengers cAMP and cGMP, which are key
CC       regulators of many important physiological processes. Has a higher
CC       efficiency with cGMP compared to cAMP (By similarity). Plays a role in
CC       cell growth and migration (By similarity).
CC       {ECO:0000250|UniProtKB:O00408}.
CC   -!- FUNCTION: [Isoform PDE2A2]: Regulates mitochondrial cAMP levels and
CC       respiration (By similarity). Involved in the regulation of mitochondria
CC       morphology/dynamics and apoptotic cell death via local modulation of
CC       cAMP/PKA signaling in the mitochondrion, including the monitoring of
CC       local cAMP levels at the outer mitochondrial membrane and of PKA-
CC       dependent phosphorylation of Dnm1l (PubMed:28463107).
CC       {ECO:0000250|UniProtKB:Q922S4, ECO:0000269|PubMed:28463107}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a nucleoside 3',5'-cyclic phosphate + H2O = a nucleoside 5'-
CC         phosphate + H(+); Xref=Rhea:RHEA:14653, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57867, ChEBI:CHEBI:58464; EC=3.1.4.17;
CC         Evidence={ECO:0000250|UniProtKB:O00408};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14654;
CC         Evidence={ECO:0000250|UniProtKB:O00408};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic GMP + H2O = GMP + H(+); Xref=Rhea:RHEA:16957,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57746,
CC         ChEBI:CHEBI:58115; Evidence={ECO:0000250|UniProtKB:O00408};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16958;
CC         Evidence={ECO:0000250|UniProtKB:O00408};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic AMP + H2O = AMP + H(+); Xref=Rhea:RHEA:25277,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58165,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:O00408};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25278;
CC         Evidence={ECO:0000250|UniProtKB:O00408};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:O00408};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions. {ECO:0000250|UniProtKB:O00408};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O00408};
CC       Note=Binds 2 divalent metal cations per subunit. Site 2 has a
CC       preference for magnesium ions. {ECO:0000250|UniProtKB:O00408};
CC   -!- ACTIVITY REGULATION: The 3',5'-cyclic-AMP phosphodiesterase activity is
CC       stimulated by 3',5'-cyclic GMP (By similarity). Specifically inhibited
CC       by Bay 60-7550. When repressed, protected from ionomycin- but not
CC       staurosporin-induced cell death. {ECO:0000250|UniProtKB:O00408,
CC       ECO:0000269|PubMed:28463107}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:O00408}.
CC   -!- INTERACTION:
CC       Q01062; Q5FWY5: Aip; NbExp=2; IntAct=EBI-1786062, EBI-1786045;
CC   -!- SUBCELLULAR LOCATION: [Isoform PDE2A3]: Cell membrane
CC       {ECO:0000250|UniProtKB:O00408}; Peripheral membrane protein
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform PDE2A1]: Cytoplasm
CC       {ECO:0000250|UniProtKB:O00408}.
CC   -!- SUBCELLULAR LOCATION: [Isoform PDE2A2]: Mitochondrion matrix
CC       {ECO:0000269|PubMed:21724846}. Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:28463107}. Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:28463107}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist. Experimental confirmation
CC         may be lacking for some isoforms.;
CC       Name=PDE2A3;
CC         IsoId=Q01062-1; Sequence=Displayed;
CC       Name=PDE2A1;
CC         IsoId=Q01062-2; Sequence=Not described;
CC       Name=PDE2A2;
CC         IsoId=Q01062-3; Sequence=Not described;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and liver.
CC       {ECO:0000269|PubMed:21724846}.
CC   -!- DOMAIN: The GAF 1 domain functions as a dimerization domain.
CC       {ECO:0000250|UniProtKB:Q922S4}.
CC   -!- DOMAIN: The GAF 2 domains binds cGMP, which acts as an allosteric
CC       activator. {ECO:0000250|UniProtKB:Q922S4}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase family.
CC       PDE2 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U21101; AAA63683.1; -; mRNA.
DR   EMBL; M94540; AAA40922.1; -; mRNA.
DR   PIR; JC2486; JC2486.
DR   RefSeq; NP_001137319.1; NM_001143847.1.
DR   RefSeq; NP_112341.1; NM_031079.1. [Q01062-1]
DR   AlphaFoldDB; Q01062; -.
DR   SMR; Q01062; -.
DR   BioGRID; 249615; 4.
DR   IntAct; Q01062; 1.
DR   STRING; 10116.ENSRNOP00000026586; -.
DR   BindingDB; Q01062; -.
DR   ChEMBL; CHEMBL4650; -.
DR   DrugCentral; Q01062; -.
DR   iPTMnet; Q01062; -.
DR   PhosphoSitePlus; Q01062; -.
DR   SwissPalm; Q01062; -.
DR   PaxDb; 10116-ENSRNOP00000026586; -.
DR   GeneID; 81743; -.
DR   KEGG; rno:81743; -.
DR   UCSC; RGD:620965; rat. [Q01062-1]
DR   AGR; RGD:620965; -.
DR   CTD; 5138; -.
DR   RGD; 620965; Pde2a.
DR   eggNOG; KOG3689; Eukaryota.
DR   InParanoid; Q01062; -.
DR   OrthoDB; 5479253at2759; -.
DR   PhylomeDB; Q01062; -.
DR   BRENDA; 3.1.4.17; 5301.
DR   Reactome; R-RNO-418457; cGMP effects.
DR   Reactome; R-RNO-418555; G alpha (s) signalling events.
DR   SABIO-RK; Q01062; -.
DR   PRO; PR:Q01062; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0097457; C:hippocampal mossy fiber; IDA:RGD.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0097060; C:synaptic membrane; IDA:RGD.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; ISS:UniProtKB.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0030552; F:cAMP binding; ISO:RGD.
DR   GO; GO:0030553; F:cGMP binding; ISO:RGD.
DR   GO; GO:0004118; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0036004; F:GAF domain binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISO:RGD.
DR   GO; GO:0042301; F:phosphate ion binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0030911; F:TPR domain binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0035904; P:aorta development; ISO:RGD.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISO:RGD.
DR   GO; GO:0003279; P:cardiac septum development; ISO:RGD.
DR   GO; GO:1904613; P:cellular response to 2,3,7,8-tetrachlorodibenzodioxine; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; ISO:RGD.
DR   GO; GO:0071321; P:cellular response to cGMP; ISS:UniProtKB.
DR   GO; GO:0097011; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:RGD.
DR   GO; GO:0046069; P:cGMP catabolic process; ISO:RGD.
DR   GO; GO:0019934; P:cGMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0060976; P:coronary vasculature development; ISO:RGD.
DR   GO; GO:0061028; P:establishment of endothelial barrier; IDA:UniProtKB.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0003170; P:heart valve development; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IMP:UniProtKB.
DR   GO; GO:0106072; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IDA:RGD.
DR   GO; GO:0010754; P:negative regulation of cGMP-mediated signaling; ISO:RGD.
DR   GO; GO:0090324; P:negative regulation of oxidative phosphorylation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0043117; P:positive regulation of vascular permeability; ISS:UniProtKB.
DR   GO; GO:0043949; P:regulation of cAMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0010752; P:regulation of cGMP-mediated signaling; ISO:RGD.
DR   GO; GO:0010821; P:regulation of mitochondrion organization; IMP:UniProtKB.
DR   GO; GO:0010749; P:regulation of nitric oxide mediated signal transduction; ISO:RGD.
DR   GO; GO:1904880; P:response to hydrogen sulfide; IEP:RGD.
DR   GO; GO:0003281; P:ventricular septum development; ISO:RGD.
DR   CDD; cd00077; HDc; 1.
DR   Gene3D; 3.30.450.40; -; 2.
DR   Gene3D; 1.10.1300.10; 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain; 1.
DR   InterPro; IPR003018; GAF.
DR   InterPro; IPR029016; GAF-like_dom_sf.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR036971; PDEase_catalytic_dom_sf.
DR   InterPro; IPR023174; PDEase_CS.
DR   PANTHER; PTHR11347; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 1.
DR   PANTHER; PTHR11347:SF102; PHOSPHODIESTERASE; 1.
DR   Pfam; PF01590; GAF; 1.
DR   Pfam; PF13185; GAF_2; 1.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00065; GAF; 3.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF55781; GAF domain-like; 3.
DR   SUPFAM; SSF109604; HD-domain/PDEase-like; 1.
DR   PROSITE; PS00126; PDEASE_I_1; 1.
DR   PROSITE; PS51845; PDEASE_I_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; cAMP; Cell membrane; cGMP; cGMP-binding; Cytoplasm;
KW   Hydrolase; Magnesium; Membrane; Metal-binding; Mitochondrion;
KW   Mitochondrion inner membrane; Mitochondrion outer membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat; Zinc.
FT   CHAIN           1..928
FT                   /note="cGMP-dependent 3',5'-cyclic phosphodiesterase"
FT                   /id="PRO_0000198798"
FT   DOMAIN          228..365
FT                   /note="GAF 1"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          397..536
FT                   /note="GAF 2"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          566..890
FT                   /note="PDEase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   REGION          188..210
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        644
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:O76083"
FT   BINDING         419
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:Q922S4"
FT   BINDING         434
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:Q922S4"
FT   BINDING         453
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:Q922S4"
FT   BINDING         476
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:Q922S4"
FT   BINDING         487
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0000250|UniProtKB:Q922S4"
FT   BINDING         648
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:O00408"
FT   BINDING         684
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:O00408"
FT   BINDING         685
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:O00408"
FT   BINDING         685
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:O00408"
FT   BINDING         796
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:O00408"
FT   MOD_RES         109
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        646
FT                   /note="W -> R (in Ref. 2; AAA40922)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        758
FT                   /note="L -> M (in Ref. 2; AAA40922)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   928 AA;  104664 MW;  EF0B8C1E266EAB18 CRC64;
     MVLVLHHILI AVVQFLRRGQ QVFLKPDEPP PQPCADSLQD ALLSLGAVID IAGLRQAAKD
     ALSAVLPKVE TVYTYLVDGE SRLVCEDPPH ELPQEGKIRE AVISRKRLSC DGLGPSDLLG
     KPLARLVAPL APDTQVLVIP LLDKETGTVA AVILVHCGQL SDSEEQSLQV VEKHALVALQ
     RVQALQQRRP EAVQNTSADP SEDQKDEKGY TAHDRKILQL CGELYDLDAT SLQLKVLRYL
     QQETQATHCC LLLVSEDNLQ LSCKVIGEKV LGEEVSFPLT MGRLGQVVED KQCIQLKDLT
     SDDVQQLQNM LGCELRAMLC VPVISRATDQ VVALACAFNK LGGDFFTDED ERAIQHCFHY
     TGTVLTSTLA FQKEQKLKCE CQALLQVAKN LFTHLDDVSV LLQEIITEAR NLSNAEICSV
     FLLDQNELVA KVFDGGVVDD ESYEIRIPAD QGIAGHVATT GQILNIPDAY AHPLFYRGVD
     DSTGFRTRNI LCFPIKNENQ EVIGVAELVN KINGPWFSKF DEDLATAFSI YCGISIAHSL
     LYKKVNEAQY RSHLANEMMM YHMKVSDDEY TKLLHDGIQP VAAIDSNFAN FTYTPRSLPE
     DDTSMAILSM LQDMNFINNY KIDCPTLARF CLMVKKGYRD PPYHNWMHAF SVSHFCYLLY
     KNLELSNYLE DIEIFALFIS CMCHDLDHRG TNNSFQVASK SVLAALYSSE GSVMERHHFA
     QAIAILNTHG CNIFDHFSRK DYQRMLDLMR DIILATDLAH HLRIFKDLQK MAEVGYDRNN
     KQHHRLLLCL LMTSCDLSDQ TKGWKTTRKI AELIYKEFFS QGDLEKAMGN RPMEMMDREK
     AYIPELQISF MEHIAMPIYK LLQDLFPKAA ELYERVASNR EHWTKVSHKF TIRGLPSNNS
     LDFLDEEYEV PDLDVTRAPV NGCCSLEG
//
